Unknown

Dataset Information

0

Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis.


ABSTRACT: BACKGROUND:Inhaled hypertonic saline (HS) has been shown to increase mucociliary clearance (MCC) and improve clinical outcomes in adults and adolescents with cystic fibrosis (CF). However, in younger children with CF, a large study failed to demonstrate clinical benefits. This discrepancy could reflect pharmacodynamic differences in the MCC response to HS in different populations. We previously demonstrated the absence of a sustained effect of HS on MCC in healthy adults and in this study sought to characterize the durability of the MCC response to HS in adults with CF. METHODS:At two study sites, MCC was measured in CF adults using gamma scintigraphy during three separate visits: at baseline, 15?min, and 4?h after a single dose of HS (7% NaCl, 4?mL). Particle clearance rates at these visits were used to assess the durability of the MCC response to HS. RESULTS:The average 90-minute clearance rate measured 4?h after HS was significantly increased (21.81%?±?12.8) when compared to baseline (13.77%?±?8.7, p?=?.048) and showed no apparent slowing relative to the rate measured 15?min after HS. While not all subjects responded to HS, the acute response strongly predicted the sustained effect in these subjects (r?=?0.896, p?

SUBMITTER: Trimble AT 

PROVIDER: S-EPMC6053331 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis.

Trimble Aaron T AT   Whitney Brown A A   Laube Beth L BL   Lechtzin Noah N   Zeman Kirby L KL   Wu Jihong J   Ceppe Agathe A   Waltz David D   Bennett William D WD   Donaldson Scott H SH  

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20180120 5


<h4>Background</h4>Inhaled hypertonic saline (HS) has been shown to increase mucociliary clearance (MCC) and improve clinical outcomes in adults and adolescents with cystic fibrosis (CF). However, in younger children with CF, a large study failed to demonstrate clinical benefits. This discrepancy could reflect pharmacodynamic differences in the MCC response to HS in different populations. We previously demonstrated the absence of a sustained effect of HS on MCC in healthy adults and in this stud  ...[more]

Similar Datasets

| S-EPMC3180295 | biostudies-literature
| S-EPMC4226497 | biostudies-literature
| S-EPMC7736104 | biostudies-literature
| S-EPMC7418818 | biostudies-literature
| S-EPMC8184161 | biostudies-literature
| S-EPMC6513595 | biostudies-literature
| S-EPMC4469922 | biostudies-literature
| S-EPMC4303949 | biostudies-literature
| S-EPMC5253607 | biostudies-literature
| S-EPMC3332252 | biostudies-literature